CADASIL患者脑出血:NOTCH3 R544C变异与高血压的叠加影响?
该横断面回顾性研究纳入法国和台湾两个独立CADASIL队列共552例患者,比较有无脑出血史者的临床与影像特征。结果显示NOTCH3 R544C变异(OR 9.91)和高血压(OR 7.90)均为脑出血的独立危险因素,两者无相乘交互作用但存在叠加效应。中介分析提示NOTCH3 R544C变异对脑出血效应的49.9%可由高血压解释。
要点
- CADASIL患者中脑出血史占6.2%,NOTCH3 R544C变异与高血压均为独立危险因素。
- NOTCH3 R544C变异合并高血压时脑出血风险呈叠加效应(36.9% vs 0.6%)。
- NOTCH3 R544C变异对脑出血的效应中49.9%可由高血压解释。
核心结论
- NOTCH3 R544C变异和高血压似乎是CADASIL患者脑出血的独立危险因素,并具有潜在叠加效应。
- 由于横断面设计和人群特异性因素,无法确定因果关系,需前瞻性研究验证。
研究设计与样本
- 横断面回顾性分析,纳入法国(2003年起招募)和台湾(2019年起招募)两个独立CADASIL队列共552例患者(法国440例,台湾112例)。
- 使用标准化问卷和量表收集临床病史与评估,采用CADA-MRIT评分工具评估神经影像特征。
- 比较有无脑出血史的患者,采用逻辑回归和中介分析识别与脑出血相关的因素。
主要发现
- 552例患者中34例(6.2%)有脑出血史。
- 脑出血患者较无脑出血者年龄更大(62.9±11.4 vs 53.4±12.3岁),NOTCH3 R544C变异比例更高(79.4% vs 15.3%),高血压比例更高(85.3% vs 24.9%)。
- 脑出血患者脑微出血更多、脑萎缩更重、基底节扩大的血管周围间隙数量更多。
- 高血压(OR 7.90 [95%CI 2.83-22.08])和NOTCH3 R544C变异(OR 9.91 [95%CI 3.84-25.57])各自独立与脑出血相关,两者无相乘交互作用(P交互=0.81)。
- 同时具有NOTCH3 R544C变异和高血压时脑出血风险呈叠加效应:两者均存在36.9%,仅有NOTCH3 R544C变异无高血压8.8%,仅有高血压无NOTCH3 R544C变异5.4%,两者均无0.6%(P趋势<0.001)。
临床怎么用
- 在CADASIL患者中,NOTCH3 R544C变异和高血压均与脑出血风险独立相关,两者并存时风险呈叠加效应。
- 该研究为横断面设计,不能确立因果关系,临床决策需结合个体情况并等待前瞻性研究验证。
局限性
- 原文述及横断面设计无法确立因果关系。
- 原文述及人群特异性因素可能影响结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intracerebral hemorrhage (ICH) is increasingly recognized in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, especially in Asian patients with the NOTCH3 R544C variant. The associations between ICH, NOTCH3 variants, and hypertension remain unclear. METHODS: We enrolled patients from 2 independent cohorts with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy in France (recruited since 2003) and Taiwan (recruited since 2019) and performed a cross-sectional retrospective analysis. Clinical history and evaluation were collected using standardized questionnaires and scales, while neuroimaging features were assessed with the CADA-MRIT inventory tool. Patients with and without a history of ICH were compared. Logistic regression and mediation analyses were conducted to identify factors associated with ICH. RESULTS: Of 552 patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (440 from France and 112 from Taiwan), 34 (6.2%) had a history of ICH. Patients with ICH were older (62.9±11.4 versus 53.4±12.3 years), had a higher proportion of the NOTCH3 R544C variant (79.4% versus 15.3%), and had hypertension (85.3% versus 24.9%). Analysis of magnetic resonance imaging data showed that they had more cerebral microbleeds, worse cerebral atrophy, and higher number of dilated perivascular spaces in basal ganglia. Hypertension (odds ratio, 7.90 [95% CI, 2.83-22.08]) and NOTCH3 R544C variant (odds ratio, 9.91 [95% CI, 3.84-25.57]) were each independently associated with ICH, while no multiplicative interaction was detected between these 2 factors (Pinteraction=0.81). Having both NOTCH3 R544C variant and hypertension carried an additive effect on the risk of ICH (36.9% if both present, 8.8% if having NOTCH3 R544C variant without hypertension, 5.4% if having hypertension without NOTCH3 R544C variant, and 0.6% if both absent; Ptrend<0.001). Finally, in the mediation analysis, 49.9% of the effects of the NOTCH3 R544C variant on the occurrence of ICH would be explained by the effects of hypertension. CONCLUSIONS: Both the NOTCH3 R544C variant and hypertension appear to be independent risk factors for ICH in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, with a potential additive effect. However, due to the study's cross-sectional design and population-specific factors, causality cannot be established. Prospective studies are thus needed to validate these findings and clarify underlying mechanisms.
引用
- Chen CH, Cheng YW, Zhang R, et al. Intracerebral Hemorrhage in Patients With CADASIL: Additive Impact of the NOTCH3 R544C Variant and Hypertension? Stroke. 2025. PMID: 40270244. doi:10.1161/STROKEAHA.124.050484
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。